The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A
Abstract
Protein kinase B (PKB) or Akt is one of several second messenger kinases that are activated by cell attachment and growth factor signaling, and that transmit signals to the cell nucleus to inhibit apoptosis and thereby increase cell survival during proliferation. Other viral proteins target this pathway by increasing PKB/Akt phosphorylation, and this pathway has been implicated in the transformation of human keratinocytes by HPV E6 and E7, together with activated notch 1. Here, we examine how HPV E7 expression affects the phosphorylation of PKB. We show that HPV-16 E7 increases the level of phosphorylation of PKB in response to serum stimulation, by a mechanism independent of downregulation of PTEN phosphatase, a known inhibitor of the PI3K (PI3 kinase) pathway. The use of specific antibodies shows that some proportion of PKB/Akt that is phosphorylated both on threonine 308 and serine 473 is maintained in the presence of E7 in a PI3 kinase-independent manner, and is activated for phosphorylation of BAD, a known downstream target of PKB/Akt. Use of E7 mutants has ruled out both an inhibition of IGFBP-3, a known E7 target and PKB/Akt modulator, and the interaction of E7 with cellular pocket proteins, as being the mechanism for the PKB/Akt stimulation. PKB binds PP2A and is a known substrate of PP2A. Here, we show that HPV E7 also binds to both the 35 kDa catalytic and 65 kDa structural subunits of PP2A, an interaction that sequesters these subunits and inhibits their interactio…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the activation of AKT signalling by high-risk E7 has been linked to the downstream activation of transcription factors leading to mmp gene expression [260,265,266]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [266]
Citations
Cites
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017 · cited 1×
“…and E7, are reflected in many of the cellular proteins with which they interact; E7 interacts with members of the pocket protein family such as pRB (Dyson et al., 1989), thus releasing transcriptional blocks on genes that express proteins required for cell-cycle progression, while E6’s first…”
Background
Research works printed but not linked: 43
- Andjelkovic M, Kakubowicz T, Cron P, Ming XF, Han JW and Hemmings BA . (1996). Proc. Natl. Acad. Sci. USA, 93, 5699–5704. · DOI
- Borgatti P, Zauli G, Colamussi M, Gibellini G, Previati M, Cantley L and Capitani S . (1997). Eur. J. Immunol., 27, 2805–2811. · DOI
- Brazil D and Hemmings BA . (2001). Trends Biochem. Sci., 26, 657–664. · DOI · Paper page
- Brunet A, Bonni A, Zigmond M, Lin M, Juo P, Hu L, Anderson M, Arden K, Blenis J and Greenberg M . (1999). Cell, 96, 857–868. · DOI · Paper page
- Crusius K, Auvinen E and Alonso A . (1997). Oncogene, 15, 1437–1444. · DOI · Paper page
- Dajee M, Tarutani M, Deng H, Cai T and Khavari PA . (2002). Oncogene, 21, 1527–1538. · DOI
- Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg ME . (1997). Cell, 91, 231–241. · DOI · Paper page
- Delcommene M, Tan C, Gray V, Rue L, Woodget J and Dedhar S . (1998). Proc. Natl. Acad. Sci. USA, 95, 11211–11216. · DOI
- Dilworth SM and Horner VP . (1993). J. Virol., 67, 2235–2244. · DOI
- Frese KK, Lee SS, Thomas DL, Latorre IJ, Weiss RS, Glaunsinger BA and Javier RT . (2003). Oncogene, 22, 710–721. · DOI
- Fujisaki H and Hattori S . (2002). Exp. Cell. Res., 280, 255–269. · DOI
- Graham FL and van der Eb AJ . (1973). Virology, 52, 456–467. · DOI
- Gu Z and Matlashewski G . (1995). J. Virol., 69, 8051–8056. · DOI · Paper page
- Hanada M, Feng J and Hemmings BA . (2004). Biochim. Biophys. Acta, 1697, 3–16. · DOI
- Harlow E and Lane D . (1988). Antibodies, A Laboratory Manual. Cold Spring Harbor Publications, Cold Spring Harbor, NY.
- Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR and Schiller JT . (1989). EMBO J., 8, 3905–3910. · DOI · Paper page
- He Y, Nakao H, Tan S-L, Polyak SJ, Neddermann P, Vijaysri S, Jacobs BL and Katze MG . (2002). J. Virol., 76, 9207–9217. · DOI
- Ishiwatari H, Hayasaka N, Inoue H, Yutsudo M and Hakura A . (1994). J. Med. Virol., 44, 243–249. · DOI
- Mannhardt B, Weinzimer SA, Wagner M, Fiedler M, Cohen P, Jansen-Durr P and Zwerschke W . (2000). Mol. Cell. Biol., 20, 6483–6495. · DOI
- Massimi P, Pim D and Banks L . (1997). J. Gen. Virol., 78, 2607–2613. · DOI
- Matlashewski G, Schneider J, Banks L, Jones N, Murray A and Crawford L . (1987). EMBO J., 6, 1741–1746. · DOI · Paper page
- Meili R, Cron P, Hemmings BA and Ballmer-Hofer K . (1998). Oncogene, 16, 903–907. · DOI
- Milburn CC, Deak M, Kelly SM, Price NC, Alessi DR and Van Aaltern DM . (2003). Biochem. J., 375, 531–538. · DOI
- Münger K, Phelps WC, Bubb V, Howley PM and Schlegel R . (1989). J. Virol., 63, 4417–4423. · DOI · Paper page
- Pallas DC, Shahrik LK, Martin BL, Jaspers S, Miller TB, Brautigan DL and Roberts TM . (1990). Cell, 60, 167–176. · DOI
- Pallas DC, Weller W, Jaspers S, Miller TB, Lane WS and Roberts TM . (1992). J. Virol., 66, 886–893. · DOI
- Pankov R, Cukierman E, Clark K, Matsumoto K, Hahn C, Poulin B and Yamada KM . (2003). J. Biol. Chem., 278, 18671–18681. · DOI
- Pim D, Massimi P and Banks L . (1997). Oncogene, 15, 257–264. · DOI
- Pouliot N, Saunders NA and Kaur P . (2002). Exp. Dermatol., 11, 387–397. · DOI
- Rangarajan A, Syal R, Selvarajah S, Chakrabarti O, Sarin A and Krishna S . (2001). Virology, 286, 23–30. · DOI
- Resjo S, Goransson O, Harndahl L, Zolnierowicz S, Manganiello V and Degerman E . (2002). Cell Signal., 14, 231–238. · DOI
- Sayama K, Yamasaki K, Hanakawa Y, Shirakata Y, Tokumaru S, Ijuin T and Hashimoto K . (2002). J. Biol. Chem., 277, 40390–40396. · DOI
- Smith DB and Johnson KS . (1988). Gene, 67, 31–40. · DOI
- Stambolic V, Mak TW and Woodgett JR . (1999). Oncogene, 18, 6094–6103. · DOI
- Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP and Mak TW . (1998). Cell, 95, 29–39. · DOI · Paper page
- Storey A, Pim D, Murray A, Osborn K, Banks L and Crawford LV . (1988). EMBO J., 7, 1815–1820. · DOI
- Summers S, Lipfert L and Birnbaum M . (1998). Biochem. Biophys. Res. Commun., 246, 76–81. · DOI
- Sun P, Wang XQ, Lopatka K, Bangash S and Paller AS . (2002). J. Invest. Dermatol., 19, 107–117. · DOI
- Troussard AA, Mawji NM, Ong C, Mui A, St-Arnaud R and Dedhar S . (2003). J. Biol. Chem., 278, 22374–22378. · DOI
- Velling T, Nilsson S, Stefansson A and Johansson S . (2004). EMBO Rep., 5, 901–905. · DOI
- Werness B, Levine A and Howley PM . (1990). Science, 248, 76–79. · DOI · Paper page
- Westbrook TF, Nguyen DX, Thrash BR and McCance DJ . (2002). Mol. Cell. Biol., 22, 7041–7052. · DOI
- Zur Hausen H . (1999). Semin. Cancer Biol., 9, 405–411. · DOI
Cited by
Narisawa‐Saito, M., & Kiyono, T. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00546.x · Cited by 528
Basukala, O., & Banks, L. (2021) · Viruses · doi:10.3390/v13101892 · Cited by 137
Self-citationNon-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer
Kauko, O., & Westermarck, J. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.01.005 · Cited by 111
Targeting PP2A in cancer: an underrated option
Sarais, F., Krempien, F., Koehn, C., Brewing, L., Classen, C. F., Walter, M., & Shokraie, O. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03560-y · Cited by 8
Metadata
- Authors
- Pim, D., Massimi, P., Dilworth, S. M., & Banks, L.
- Venue
- Oncogene
- Published
- 2005-07-25
- Volume
- 24
- Issue
- 53
- Pages
- 7830-7838
- ISSN
- 0950-9232
- 1476-5594
- Cited by
- 156
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review